Nachrichten zur Pfizer Inc. Aktie

PFEs Oncology & Obesity Pipeline Position It for Post-LOE Growth

Pfizer faces revenue pressure from 2026-2030 LOEs but is betting on a strengthened oncology and obesity pipeline to fuel sustainable…

Pfizer (PFE) Stock Slides as Market Rises: Facts to Know Before You Trade

In the latest trading session, Pfizer (PFE) closed at $24.88, marking a -1.31% move from the previous day.…

Better Buy in 2026: Pfizer or Merck?

This year has been one to forget for these pharmaceutical giants.…

Pfizer Isnt Dead Money, Pipeline Execution Can Spark A Rebound

…

Pfizer Down After It Issues Muted 2026 Outlook: How to Play the Stock

Pfizer shares fall after a muted 2026 outlook, with projected modest revenue growth, lower COVID sales and deal dilution weighing…

Better Buy in 2026: Pfizer or Eli Lilly?

These two stocks have been going in opposite directions over the past few years.…

Pfizer 2026: Übergangsjahr mit klarer strategischer Agenda

Pfizer stellt das Jahr 2026 bewusst unter das Zeichen des Übergangs. Nach dem außergewöhnlichen COVID Zyklus rückt der Konzern in…

Stock Market Today, Dec. 16: Pfizer Falls After Cutting 2025 Revenue Forecast

Today, Dec. 16, 2025, Pfizers shrinking COVID cash flows could mean little growth next year as M&A bets will take…

Pfizer (PFE) Registers a Bigger Fall Than the Market: Important Facts to Note

In the latest trading session, Pfizer (PFE) closed at $25.57, marking a -3.27% move from the previous day.…

Wall Street-Schluss: Dow gibt nach - Tesla mit starker Performance, Pfizer verliert

An den US-Börsen ist es am Dienstag erneut abwärts gegangen. Die Verluste weiteten sich im Handelsverlauf aus, denn unter den…

Jefferies belässt Pfizer auf Buy - Ziel 34 Dollar

NEW YORK (dpa-AFX Analyser) - Das Analysehaus Jefferies hat die Einstufung für Pfizer nach Zahlen und einem Geschäftsausblick auf 2025…

Stocks making the biggest moves premarket: Pfizer, Roku, Kraft Heinz & more

These are the stocks posting the largest moves in early trading.…

Pfizer’s modest 2026 outlook shows its big investments will take time to pay off

Pfizer has pursued deals of all sizes to build new revenue streams, but the outlook underscores that those investments are…

Pfizer erwartet 2026 weniger Gewinn - Covid-Umsatz rückläufig

NEW YORK (dpa-AFX) - Der US-Pharmakonzern Pfizer erwartet für das kommende Jahr aufgrund rückläufiger Umsätze…

Pfizer Neutral

NEW YORK (dpa-AFX Analyser) - Die US-Bank JPMorgan hat die Einstufung für Pfizer mit einem Kursziel von 30 US-Dollar auf…

Market movers: Circle, Pfizer, Reconnaissance Energy Africa...

…

dpa-AFX-Überblick: UNTERNEHMEN vom 16.12.2025 - 15.15 Uhr

Pfizer erwartet 2026 weniger Gewinn - Covid-Umsatz rückläufig NEW YORK - Der US-Pharmakonzern Pfizer erwartet für…

Pfizer erwartet 2026 weniger Gewinn - Covid-Umsatz rückläufig

NEW YORK (dpa-AFX) - Der US-Pharmakonzern Pfizer erwartet für das kommende Jahr aufgrund rückläufiger Umsätze mit Covid-Medikamenten weniger Gewinn.…

JPMorgan belässt Pfizer auf Neutral - Ziel 30 Dollar

NEW YORK (dpa-AFX Analyser) - Die US-Bank JPMorgan hat die Einstufung für Pfizer mit einem Kursziel von 30 US-Dollar auf…

Pfizer shares fall after it forecasts 2026 revenue below estimates

Pfizer Inc (NYSE:PFE, XETRA:PFE) said on Tuesday that its 2026 revenue and profit are expected to come in slightly below…

Where Will Eli Lilly Be in 10 Years?

In a decade, Eli Lilly could be in the same place that Pfizer finds itself in today.…

Pfizer Aktie: Neues Kursziel von Morgan Stanley wirkt wie eine Kampfansage

Bad Marienberg (www.aktiencheck.de) - Pfizer: Was Morgan Stanley beim US-Pharmakonzern jetzt wirklich siehtPfizer Inc. (ISIN: US7170811035, WKN: 852009, Ticker-Symbol: PFE,…

Pfizer Is Still Struggling to Replace Its COVID Revenue. Heres What We Could See From the Pharmaceutical Giant in 2026.

Keep your expectations in check.…

The Best Turnaround Stock to Invest $1,000 in Right Now

Pfizer and Bristol Myers Squibb are deeply out-of-favor drugmakers, but one could be the better turnaround candidate if you think…

Pfizer Neutral

NEW YORK (dpa-AFX Analyser) - Die US-Bank JPMorgan hat die Einstufung für Pfizer mit einem Kursziel von 30 US-Dollar auf…

Down 50%, Should You Buy the Dip on Pfizer?

Pfizers stock has fallen by more than 50% from its 2021 highs and faces some headwinds, but remains worth a…

Pfizer adds to obesity bet with up to $2.1 billion deal to develop Chinese companys pill

The deal will help Pfizer beef up and diversify its obesity drug pipeline following its $10 billion acquisition of obesity…

CRDF: Initiating Coverage – Combination Therapy Elicits Superior Response

By John Vandermosten, CFA NASDAQ:CRDFREAD THE FULL CRDF RESEARCH REPORTWe are initiating coverage of Cardiff Oncology, Inc.…

Eli Lilly, Pfizer Land on China’s First Private Insurance List

Eli Lilly & Co., Pfizer Inc. and Johnson & Johnson secured spots on China’s first innovative drug catalog, opening a…

Pfizer (PFE) Up 3.9% Since Last Earnings Report: Can It Continue?

Pfizer (PFE) reported earnings 30 days ago. Whats next for the stock? We take a look at earnings estimates for…

Pfizers Cancer Drugs Deliver Growth Amid Competitive Pressure

Pfizers expanding oncology portfolio, rising sales of key therapies, and steady pipeline progress reinforce its long-term cancer strategy momentum.…

If You Invested $10K In Pfizer Stock 10 Years Ago, How Much Would You Have Now?

Pfizer Inc. (NYSE:PFE) is a global biopharmaceutical company that discovers, develops, manufactures, and markets medicines, vaccines, and healthcare products. It…

Pfizer: The Patent Cloud Is An Opportunity For Bargain Hunters

…

Pfizer, Mastercard Among 24 Companies To Announce Annual Increases In December

…

BridgeBio (BBIO) Q3 2025 Earnings Call Transcript

Image source: The Motley Fool.DATEOct. 29, 2025 at 10:56 p.m. ETCALL PARTICIPANTSChief Executive Officer — Neil KumarPresident and Chief Financial…

Novo Nordisk or Pfizer: Which Healthcare Giant Is the Better Bet?

PFEs oncology gains and obesity re-entry contrast with NVOs GLP-1 pressures in this in-depth comparison of two healthcare giants.…

Big Pharma im Schlagabtausch – wer hat die Nase vorn?

Merck & Co und Pfizer sind zwei absolute Schwergewichte in der Pharmabranche. Nur eine Aktie ist aber derzeit ein Kauf.…

AbbVie and Pfizer: A Closer Look at Two Pharma Heavyweights

ABBVs surging immunology sales and smoother LOE path stand out as both drugmakers face a pivotal 2026.…

Pfizer Hold

HAMBURG (dpa-AFX Analyser) - Die Privatbank Berenberg hat Pfizer auf "Hold" mit einem Kursziel von 25 US-Dollar belassen. Nach der…

Did Pfizer Just Say "Checkmate" to Novo Nordisk?

The weight loss drug market may approach almost $100 billion by the end of the decade.…

Is Pfizers 6.9%-Yielding Dividend Still Safe?

The companys earnings fell by 21% last quarter.…

Pfizer: Is This Pharma Giant Finally A Bargain

…

Pfizer Inc. (PFE) Presents at Jefferies London Healthcare Conference 2025 Transcript

…

2 Giant Healthcare Stocks to Buy Hand Over Fist in November

Consider buying Medtronic for its dividend and Pfizer for its turnaround potential if you are looking for attractive healthcare investments…

Down 55%, Should You Buy the Dip on Pfizer?

Pfizer is a pharmaceutical industry giant facing normal pharmaceutical industry headwinds; it will survive.…

Pfizers Rich Dividend Story Meets Overpriced Metsera Acquisition/Patent Cliff Risks

…

Activist Starboard sells Pfizer stake after pushing for changes By Reuters

Activist Starboard sells Pfizer stake after pushing for changes…

Iterum Therapeutics (ITRM) Earnings Transcript

Image source: The Motley Fool.DATEFriday, November 14, 2025 at 8:30 a.m. ETCALL PARTICIPANTSChief Executive Officer — Corey N. FishmanChief Financial…

Pfizers ex-R&D chief Dolsten withdraws from Novo Nordisk board race

Mikael Dolsten, Pfizers former research and development chief, has withdrawn his candidacy for Novo Nordisks board, citing personal reasons, the…

Pfizer sheds BioNTech stake years after blockbuster COVID vaccine tie-up

Pfizer Inc said on Thursday said that it will sell 54.7% of its stake in German drugmaker BioNTech SE ,…